Mibelas 24 Fe Kit
Product Images NDC 68180-911

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mibelas 24 Fe (NDC 68180-911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (5a435cc5 553b 4f46 9241 Ebb17ff08095 01)

A forest plot titled 'Relevant Studies of Risk of Breast Cancer with Combined Oral Contraceptives' showing effect estimates with confidence intervals for various studies comparing risk in ever users vs. never users and current users vs. never users of combined oral contraceptives. The x-axis represents effect estimates ranging from -1.5 to 2.0, and each study's odds ratio, relative risk, or hazard ratio with confidence intervals is displayed as horizontal lines with data points on the plot.*

FDA Label Image

Ethinyl Estradiol (5a435cc5 553b 4f46 9241 Ebb17ff08095 02)

Chemical structure of the active ingredient shown in the image, depicting a steroid-like molecular framework with hydroxyl, methyl, and alkyne functional groups, consistent with a complex organic compound.*

FDA Label Image

Norethindrone Acetate (5a435cc5 553b 4f46 9241 Ebb17ff08095 03)

Chemical structure diagram showing the molecular structure of the active ingredient associated with Mibelas 24 Fe by Lupin Pharmaceuticals, Inc. The diagram displays carbon rings, hydrogen atoms, and functional groups as typical in steroid-related compounds.*

FDA Label Image

Figure 2 (5a435cc5 553b 4f46 9241 Ebb17ff08095 04)

A line graph depicting norethindrone concentration (pg/mL) over time (hours), showing a peak concentration within the first few hours and gradual decline from 0 to 36 hours, with error bars representing variability at each time point.*

FDA Label Image

Figure 4 (5a435cc5 553b 4f46 9241 Ebb17ff08095 05)

A line graph showing the concentration of ethinyl estradiol (pg/mL) over time (hours) up to 36 hours. Data points indicate a peak concentration around 2-3 hours followed by a gradual decline, with error bars representing variability at each time point.*

FDA Label Image

Figure 5 (5a435cc5 553b 4f46 9241 Ebb17ff08095 06)

A vertical categorical chart showing contraception methods ranked by pregnancy frequency per 100 women in one year. Methods like sterilization, implants, injections, and hormonal birth control pills are linked to fewer pregnancies, while no birth control corresponds to the most pregnancies. Other methods such as condoms, natural family planning, and withdrawal fall in intermediate positions.*

FDA Label Image

Blister Image (5a435cc5 553b 4f46 9241 Ebb17ff08095 07)

This image shows a dosing schedule chart for Mibelas 24 Fe chewable tablets (1 mg/0.02 mg norethindrone acetate and ethinyl estradiol with ferrous fumarate), labeled by Lupin Pharmaceuticals, Inc. It outlines a 4-week cycle with days of the week and arrows indicating the order to take the tablets, including instructions for day 1 starters to align with their menstrual cycle. Storage conditions are also noted.*

FDA Label Image

Carton Label (5a435cc5 553b 4f46 9241 Ebb17ff08095 08)

Mibelas 24 Fe chewable tablets package label with active ingredients norethindrone acetate and ethinyl estradiol, plus ferrous fumarate. The strength of the tablets is 1 mg/0.02 mg. Label shows the product NDC 68180-911-73 and indicates a 3 blister pack of 28 tablets each, distributed by Lupin Pharmaceuticals, Inc. The design has a purple gradient background with a floral logo and includes usage warnings and manufacturing details.*

FDA Label Image

Pouch Label (5a435cc5 553b 4f46 9241 Ebb17ff08095 09)

Label for Mibelas 24 Fe chewable tablets by Lupin Pharmaceuticals, Inc. The product contains norethindrone acetate 1 mg, ethinyl estradiol 0.02 mg, and ferrous fumarate tablets. The label indicates a 24-day active therapy supply with one blister of 28 tablets in the pouch. It includes usage warnings and regulatory information.*

FDA Label Image

Blister Label (5a435cc5 553b 4f46 9241 Ebb17ff08095 10)

Packaging label for Mibelas 24 Fe chewable tablets containing norethindrone acetate 1 mg and ethinyl estradiol 0.02 mg with ferrous fumarate. The label includes a four-week calendar layout for daily dosing, a barcode, storage instructions at 25°C (77°F), and details on distribution by Lupin Pharmaceuticals, Inc. and manufacturing by Lupin Limited in India. The label also features spaces for lot number and expiration date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.